Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Public ClinicalTrials.gov record NCT01580696. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase I/IIa Trial of Folate Binding Protein (FBP) Peptide (E39) Vaccine in Ovarian and Endometrial Cancer Patients
Study identification
- NCT ID
- NCT01580696
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- COL George Peoples, MD, FACS
- Federal
- Enrollment
- 51 participants
Conditions and interventions
Interventions
- E39 peptide (100mcg)/GM-CSF vaccine plus E39 booster Biological
- Non-vaccine clinically matched control group Other
- E39 peptide (500mcg)/GM-CSF vaccine plus E39 booster Biological
- E39 peptide (1000mcg)/GM-CSF vaccine plus E39 booster Biological
- E39 peptide (100mcg)/GM-CSF vaccine plus J65 booster Biological
- E39 peptide (500mcg)/GM-CSF vaccine plus J65 booster Biological
- E39 peptide (1000mcg)/GM-CSF vaccine plus J65 booster Biological
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2012
- Primary completion
- Jul 30, 2016
- Completion
- Jul 30, 2016
- Last update posted
- May 3, 2020
2012 – 2016
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mid-Atlantic Gynecologic Oncology & Pelvic Surgery Associates | Annandale | Virginia | 22003 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01580696, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01580696 live on ClinicalTrials.gov.